Published in Circulation on November 01, 1993
Shadows of complexity: what biological networks reveal about epistasis and pleiotropy. Bioessays (2009) 1.82
EPIC-Heart: the cardiovascular component of a prospective study of nutritional, lifestyle and biological factors in 520,000 middle-aged participants from 10 European countries. Eur J Epidemiol (2007) 1.59
Genome-wide association study for circulating tissue plasminogen activator levels and functional follow-up implicates endothelial STXBP5 and STX2. Arterioscler Thromb Vasc Biol (2014) 1.45
Oxidative risk for atherothrombotic cardiovascular disease. Free Radic Biol Med (2009) 1.24
High levels of tissue plasminogen activator (tPA) antigen precede the development of type 2 diabetes in a longitudinal population study. The Northern Sweden MONICA study. Cardiovasc Diabetol (2003) 0.89
Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects. Cardiovasc Diabetol (2011) 0.88
The effects of polymorphisms in genes from the renin-angiotensin, bradykinin, and fibrinolytic systems on plasma t-PA and PAI-1 levels are dependent on environmental context. Hum Genet (2007) 0.87
Male-female differences in the genetic regulation of t-PA and PAI-1 levels in a Ghanaian population. Hum Genet (2008) 0.86
4G/5G polymorphism of PAI-1 gene and Alu-repeat I/D polymorphism of TPA gene in Turkish patients with polycystic ovary syndrome. J Assist Reprod Genet (2007) 0.83
Increased tissue plasminogen activator levels in patients with nonvalvular atrial fibrillation. CMAJ (1997) 0.81
In young post-myocardial infarction male patients elevated plasminogen activator inhibitor-1 correlates with insulin resistance and endothelial dysfunction. Heart Vessels (2012) 0.79
Plasma Concentration of Endogenous Tissue Plasminogen Activator and the Occurrence of Future Cardiovascular Events. J Thromb Thrombolysis (1994) 0.78
Leptin as a cardiovascular risk factor. Hippokratia (2007) 0.77
Three months of strictly controlled daily endurance exercise reduces thrombin generation and fibrinolytic risk markers in younger moderately overweight men. Eur J Appl Physiol (2015) 0.76
Lack of association between Ser(413)/Cys polymorphism of plasminogen activator inhibitor type 2 (PAI-2) and premature coronary atherosclerotic disease. EXCLI J (2012) 0.75
Spontaneous recanalization of a completely occluded saphenous vein graft two months following acute myocardial infarction with persistent one year patency. J Thromb Thrombolysis (2009) 0.75
von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Br Heart J (1991) 1.83
High concentration of thrombomodulin in plasma is associated with hemorrhage: a prospective study in patients receiving long-term anticoagulant treatment. Circulation (1997) 1.47
Von Willebrand factor predicts major bleeding and mortality during oral anticoagulant treatment. J Intern Med (2011) 1.41
Diagnostic accuracy of plasma biomarkers for intestinal ischaemia. Scand J Clin Lab Invest (2008) 1.20
Autonomic cardiovascular regulation in patients with obstructive sleep apnoea: a study based on spectral analysis of heart rate variability. Clin Physiol (2000) 1.08
A novel panel of cerebrospinal fluid biomarkers for the differential diagnosis of Alzheimer's disease versus normal aging and frontotemporal dementia. Dement Geriatr Cogn Disord (2007) 1.07
Serum lipids, glucose and insulin levels in healthy schoolchildren aged 9 and 15 years from Central Sweden: reference values in relation to biological, social and lifestyle factors. Scand J Clin Lab Invest (2005) 1.07
D-dimer testing in patients with suspected acute thromboembolic occlusion of the superior mesenteric artery. Br J Surg (2004) 1.05
Prealbumin in Swedish patients with senile systemic amyloidosis and familial amyloidotic polyneuropathy. Scand J Immunol (1985) 1.03
Evidence for increased levels of plasminogen activator inhibitor and tissue plasminogen activator in plasma of patients with angiographically verified coronary artery disease. Eur Heart J (1989) 1.00
Preliminary study of D-dimer as a possible marker of acute bowel ischaemia. Br J Surg (2001) 0.99
Ischemic stroke. Impact of a recent myocardial infarction. Stroke (1999) 0.98
Interrelationships between plasma levels of plasminogen activator inhibitor, tissue plasminogen activator, lipoprotein (a), and established cardiovascular risk factors in a north Swedish population. Atherosclerosis (1989) 0.98
Prealbumin variants in the amyloid fibrils of Swedish familial amyloidotic polyneuropathy. Clin Exp Immunol (1987) 0.97
Low and high circulating cortisol levels predict mortality and cognitive dysfunction early after stroke. J Intern Med (2004) 0.97
Cardiac involvement in congenital myotonic dystrophy. Br Heart J (1990) 0.95
Atrioventricular and intraventricular conduction in familial amyloidosis with polyneuropathy. Acta Med Scand (1980) 0.89
Tissue plasminogen activator and other risk factors as predictors of cardiovascular events in patients with severe angina pectoris. Eur Heart J (1991) 0.89
Echocardiographic features in familial amyloidosis with polyneuropathy. Acta Med Scand (1983) 0.89
The effect of streptokinase neutralizing antibodies on fibrinolytic activity and reperfusion following streptokinase treatment in acute myocardial infarction. J Intern Med (2002) 0.88
Improved fibrinolysis by intense lifestyle intervention. A randomized trial in subjects with impaired glucose tolerance. J Intern Med (1999) 0.86
Endurance physical activity, diet and fibrinolysis. Atherosclerosis (1994) 0.86
Randomised controlled short-term intervention pilot study on rye bran bread in prostate cancer. Eur J Cancer Prev (2003) 0.85
The sick sinus syndrome in familial amyloidosis with polyneuropathy. Int J Cardiol (1983) 0.85
The cardiac atrioventricular conduction system in familial amyloidosis with polyneuropathy. A clinico-pathologic study of six cases from Northern Sweden. Acta Pathol Microbiol Immunol Scand A (1983) 0.85
Spectral analysis of heart rate variability in patients with irritable bowel syndrome. Scand J Gastroenterol (1998) 0.84
Disturbances of cardiac rhythm and conduction in familial amyloidosis with polyneuropathy. Br Heart J (1984) 0.84
Blood collection in strong acidic citrate anticoagulant used in a study of dietary influence on basal tPA activity. Thromb Haemost (1989) 0.82
The sinoatrial node in familial amyloidosis with polyneuropathy. A clinico-pathological study of nine cases from northern Sweden. Virchows Arch A Pathol Anat Histopathol (1984) 0.82
Serum prealbumin and retinol-binding protein in the prealbumin-related senile and familial forms of systemic amyloidosis. Lab Invest (1985) 0.82
Pulmonary function in familial amyloidosis with polyneuropathy. Acta Med Scand (1981) 0.82
Pulsed tissue Doppler and strain imaging discloses early signs of infiltrative cardiac disease: a study on patients with familial amyloidotic polyneuropathy. Eur J Echocardiogr (2006) 0.81
Increased levels of plasma thrombomodulin are associated with vascular and all-cause mortality in patients on long-term anticoagulant treatment. Eur Heart J (1996) 0.81
Heart valve involvement in familial amyloidosis with polyneuropathy. Pathol Res Pract (1986) 0.80
Hypo-fibrinolysis in patients with hypertension and elevated cholesterol. J Intern Med (1991) 0.80
Ventricular dysfunction in type 1 myotonic dystrophy: electrical, mechanical, or both? Int J Cardiol (2009) 0.80
Protein markers for the differential diagnosis of vascular dementia and Alzheimer's disease. Int J Proteomics (2012) 0.79
Propafenone versus disopyramide for treatment of chronic symptomatic ventricular arrhythmias. A multicenter study. Acta Med Scand (1988) 0.79
Homozygosity for the C677-->T mutation of 5,10-methylenetetrahydrofolate reductase and total plasma homocyst(e) ine are not associated with greater than normal risk of a first myocardial infarction in northern Sweden. Coron Artery Dis (2001) 0.79
Autonomic neuropathy in familial amyloidotic polyneuropathy. A clinical study based on heart rate variability. Acta Neurol Scand (1989) 0.79
Thrombocytosis in active rheumatoid arthritis. Relation to other parameters of inflammatory activity and confounding effect of automated cell counting. Clin Rheumatol (1988) 0.79
Effects of partial hepatectomy on plasma fibronectin concentrations in the rat. Br J Exp Pathol (1987) 0.79
Electrophysiologic evaluation of the cardiac conduction system and its autonomic regulation in familial amyloid polyneuropathy. Am J Cardiol (1985) 0.78
Cardiac involvement in familial amyloidosis with polyneuropathy. Int J Cardiol (1983) 0.78
Influence of prolonged dalteparin treatment on coagulation, fibrinolysis and inflammation in unstable coronary artery disease. J Intern Med (2005) 0.78
Folate-metabolizing gene variants and pregnancy outcome of IVF. Reprod Biomed Online (2011) 0.78
Increased fibrinogen levels and acquired hypofibrinolysis in young adults with ischemic stroke. Stroke (1998) 0.78
Prealbumin: its association with amyloid. J Clin Pathol (1987) 0.78
Endothelial haemostatic factors may be associated with mortality in patients on long-term anticoagulant treatment. Thromb Haemost (1995) 0.78
Heart-rate variation: what are we measuring? Clin Physiol (1993) 0.78
Differentiation of cardiac amyloidosis and hypertrophic cardiomyopathy. A comparison of familial amyloidosis with polyneuropathy and hypertrophic cardiomyopathy by electrocardiography and echocardiography. Acta Med Scand (1987) 0.77
Hemodynamic and angiocardiographic observations in familial amyloidosis with polyneuropahy. Acta Med Scand (1982) 0.77
Qualitative platelet defects in chronic myeloproliferative disorders: evidence for reduced ATP secretion. Eur J Haematol (1989) 0.77
Pacemaker treatment in familial amyloidosis with polyneuropathy. Pacing Clin Electrophysiol (1984) 0.77
Plasma glucose and insulin, urinary catecholamine and cortisol responses to test breakfasts with high or low fibre content: the importance of the previous diet. Ann Nutr Metab (1989) 0.77
Prevalence of coronary artery disease in patients with valvular heart disease. Acta Med Scand (1985) 0.77
Altered mRNA expression due to acute mesenteric ischaemia in a porcine model. Eur J Vasc Endovasc Surg (2010) 0.77
Normal plasminogen activator inhibitor levels at long-term follow-up after jejuno-ileal bypass surgery in morbidly obese individuals. Metabolism (1992) 0.77
Effects of doxazosin and atenolol on the fibrinolytic system in patients with hypertension and elevated serum cholesterol. Eur J Clin Pharmacol (1991) 0.77
Intense nonpharmacological intervention in subjects with multiple cardiovascular risk factors: decreased fasting insulin levels but only a minor effect on plasma plasminogen activator inhibitor activity. Metabolism (1998) 0.77
Effects on fibrinolytic activity of corn oil and a fish oil preparation enriched with omega-3-polyunsaturated fatty acids in a long-term study. Curr Med Res Opin (1993) 0.77
Fibrinolytic variables are related to age, sex, blood pressure, and body build measurements: a cross-sectional study in Norsjö, Sweden. J Clin Epidemiol (1989) 0.76
Impact of liver transplantation on autonomic neuropathy in familial amyloidotic polyneuropathy: an evaluation by spectral analysis of heart rate variability. J Intern Med (1997) 0.76
Cardiac arrhythmias in familial amyloid polyneuropathy during anaesthesia. Acta Anaesthesiol Scand (1986) 0.76
Adrenal steroid dysregulation in dystrophia myotonica. J Intern Med (1999) 0.76
Assessment of autonomic nerve function in acute intermittent porphyria; a study based on spectral analysis of heart rate variability. J Intern Med (1996) 0.76
Blood cell telomere length among patients with an isolated popliteal artery aneurysm and those with multiple aneurysm disease. Atherosclerosis (2011) 0.76
Tissue plasminogen activator, plasminogen activator inhibitor-1 and von Willebrand factor in rheumatoid arthritis. Clin Rheumatol (1993) 0.76
Pyrosequencing assay for genotyping of the Transcobalamin II 776C>G polymorphism. Scand J Clin Lab Invest (2007) 0.76
Binding of tissue plasminogen activator to human endothelial cells. Importance of the B-chain as a ligand. Biochem J (1992) 0.75
Impact of autonomic neuropathy on circulatory instability during liver transplantation for familial amyloidotic polyneuropathy. Transplantation (1997) 0.75
[Familial amyloidosis with polyneuropathy in Sweden - a review]. Lakartidningen (1983) 0.75
Hyperhomocysteinemia and hypofibrinolysis in young adults with ischemic stroke. Stroke (1999) 0.75
Production of lactate and tissue plasminogen activator in vitro by seminiferous tubules obtained from adult unilaterally cryptorchid rats. Arch Androl (1987) 0.75
The effect of body build, diet and endocrine factors on the extrinsic fibrinolytic system in healthy young women. Scand J Clin Lab Invest (1988) 0.75
Cloxacillin concentrations in serum, subcutaneous fat, and muscle in patients with chronic critical limb ischemia. Eur J Clin Pharmacol (2014) 0.75
[Modern pacemaker--a review]. Lakartidningen (1982) 0.75
Experimental haemorrhage and blood component transfusion in humans: no change in plasma concentration of thrombin-antithrombin complex and plasmin-antiplasmin complex. Thromb Res (1996) 0.75
Highly refractile myocardial echoes in familial amyloidosis with polyneuropathy. A correlative echocardiographic and histopathological study. Acta Med Scand (1985) 0.75
Cardiopulmonary function in sarcoidosis. Acta Med Scand (1984) 0.75
24-hour electrocardiographic study in myotonic dystrophy. Cardiology (1988) 0.75
Thrombomodulin and acute bleeding duodenal ulcer. J Intern Med (1999) 0.75
Cardiac stimulation threshold in familial amyloidosis with polyneuropathy. Pacing Clin Electrophysiol (1987) 0.75
Elevated plasma homocysteine: cause or consequence of myocardial infarction? J Intern Med (2004) 0.75
Increased plasminogen activator inhibitor and tissue plasminogen activator levels in subjects with electrocardiographic abnormality indicative of ischaemic heart disease: a cross-sectional study in Norsjö, Sweden. Eur Heart J (1992) 0.75
Effects of ethinyl oestradiol/polyoestradiol phosphate and estramustine phosphate on some proteins related to haemostasis in prostatic carcinoma patients. Int Urol Nephrol (1991) 0.75
Electrocardiographic findings in myotonic dystrophy. Arctic Med Res (1988) 0.75
Long-term follow up of von Willebrand factor and plasminogen activator inhibitor-1 in patients with polymyalgia rheumatica. Ann Rheum Dis (1997) 0.75
Myeloma-associated cardiac amyloidosis. A case report. Acta Med Scand (1984) 0.75
Prevalence of anti-endothelial cell antibodies in patients with autoimmune diseases. Clin Rheumatol (1992) 0.75
Impact of acute phase on concentrations of tissue plasminogen activator and plasminogen activator inhibitor in plasma after deep-vein thrombosis or open-heart surgery. Clin Chem (1989) 0.75
Familial amyloidotic polyneuropathy in northern Sweden. A cross-sectional and longitudinal study of cardiac function with echocardiography. Arctic Med Res (1988) 0.75
Bleeding time and concentrations of von Willebrand factor in patients with acute upper gastrointestinal bleeding. Eur J Surg (1996) 0.75
Platelet clumping in Ph-negative myeloproliferative syndromes. Acta Med Scand (1987) 0.75
Retinoids and fibrinolysis. Acta Derm Venereol (1995) 0.75